A Phase I/II Study of 166Ho-DOTMP With Peripheral Blood Progenitor Cell Support for Refractory or Recurrent Ewing's Sarcoma Family of Tumors With Bone Disease.
Phase of Trial: Phase I/II
Latest Information Update: 30 Nov 2011
At a glance
- Drugs Holmium-166-DOTMP (Primary)
- Indications Ewing's sarcoma; Rhabdomyosarcoma
- Focus Therapeutic Use
- 30 Nov 2011 Actual end date (1 Mar 2006) added as reported by ClinicalTrials.gov.
- 19 Nov 2005 New trial record.